Effect of dietary carbohydrate restriction on cardiometabolic function in type 2 diabetes: weight loss and beyond
- PMID: 37278294
- DOI: 10.1097/MCO.0000000000000946
Effect of dietary carbohydrate restriction on cardiometabolic function in type 2 diabetes: weight loss and beyond
References
-
- Klein S, Gastaldelli A, Yki-Jarvinen H, Scherer PE. Why does obesity cause diabetes? Cell Metab 2022; 34:11–20.
-
- Mohebi R, Chen C, Ibrahim NE, et al. Cardiovascular disease projections in the United States based on the 2020 census estimates. J Am Coll Cardiol 2022; 80:565–578.
-
- Pearson-Stuttard J, Holloway S, Polya R, et al. Variations in comorbidity burden in people with type 2 diabetes over disease duration: a population-based analysis of real-world evidence. EClinicalMedicine 2022; 52:101584.
-
- Magkos F, Mittendorfer B. Editorial: Type 2 diabetes therapeutics: weight loss and other strategies. Curr Opin Clin Nutr Metab Care 2022; 25:256–259.
-
- Yoshino M, Yoshino J, Smith GI, et al. Worksite-based intensive lifestyle therapy has profound cardiometabolic benefits in people with obesity and type 2 diabetes. Cell Metab 2022; 34:1431–1441.e1435.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
